股价表现 - 公司股价本周飙升23%，过去五年累计上涨124% [1] 第三季度财务业绩 - 第三季度收入达25亿美元，同比增长23%，增速较第二季度的21%有所加快 [4] - 过去12个月的息税前利润（EBIT）率扩大至29%，且自2023年初以来持续增长 [4] - 公司斥资近20亿美元回购了400万股普通股 [5] - 季度末现金头寸为95亿美元 [5] 业务运营与增长动力 - 第三季度共安装427台手术系统，高于2024年第三季度的379台和2025年第二季度的395台 [4] - 公司预计2025年达芬奇手术量将增长17%，显示机器人手术在全球的稳定渗透 [6] - 过去10年公司累计收入增长300%，预计未来可保持两位数年增长率 [8] - 机器人手术是巨大的增长领域，公司多年来主导市场 [8] 估值水平 - 公司股票当前市盈率（P/E）为73倍，接近其过去十年最高水平，是标普500平均水平的逾两倍 [9]

And here joining me with some other names to watch, Diane King Hall is with me and looking at the rally that we are seeing in a name called Intuitive Surgical. Now this one up here. >> Yes.Doubledigit move off the back of this and this has to do with basically people during the pandemic putting off all those procedures. So Intuitive Surgical the beneficiary of that. A lot of that has to do with their Da Vinci robotic system.So they beat expectations. Let me take you through some of the headline numbers. 240 ...